Sino Medical Sciences Technology Inc. (SHA:688108)
China
· Delayed Price · Currency is CNY 9.49
+0.02 (0.21%)
Apr 24, 2025, 2:45 PM CST
SHA:688108 Revenue
In the year 2024, Sino Medical Sciences Technology had annual revenue of 458.74M CNY with 33.64% growth. Sino Medical Sciences Technology had revenue of 140.25M in the quarter ending December 31, 2024, with 42.19% growth.
Revenue
458.74M
Revenue Growth
+33.64%
P/S Ratio
8.54
Revenue / Employee
703.59K
Employees
652
Market Cap
3.92B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 458.74M | 115.48M | 33.64% |
| Dec 31, 2023 | 343.26M | 150.40M | 77.99% |
| Dec 31, 2022 | 192.85M | -1.50M | -0.77% |
| Dec 31, 2021 | 194.36M | -133.06M | -40.64% |
| Dec 31, 2020 | 327.42M | -108.49M | -24.89% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 27.98B |
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| WuXi AppTec | 37.92B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
| Aier Eye Hospital Group | 20.62B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Yunnan Baiyao Group Co.,Ltd | 40.03B |
| Shanghai United Imaging Healthcare | 10.30B |